Please see below a list of all our HGLSF investments by sector. To go to individual portfolio companies websites please click on company logo.
Medical Devices / Instrumentation
General Surgical Innovations: US - Exited
First investment: 2008 - Early Stage
Minimally invasive approach to hernia repair and incontinence (purchased by United States Surgical).
Genosis: UK
First investment: 2008 - Start Up
Genosis has developed home use diagnostic devices to assess fertility in couples of
childbearing age. Genosis’ products - Fertell, which provide both male and female tests, are
available over the counter in the UK and the US and provide couples with the tools required to
assess their fertility in the privacy of their homes.
Leica Microsystems: Germany - Exited
First investment: 2008 - Buy Out
Manufactures and markets microscopes and neurosurgical equipment.
MedNova: Ireland - Exited
First investment: 2008 - Start Up
Devices for interventional radiology and cardiology.
Micromass: UK - Exited
First investment: 2008 - Buy Out
Minimally invasive approach to hernia repair and incontinence (purchased by Waters).
MicroMed: US
First investment: 2008 - Early Stage
Based in Houston, TX, MicroMed has developed an implantable pump for use as a Left Ventricular Assist Device (LVAD) to aid the heart’s pumping action in patients suffering from
congestive heart failure.
Nexan: UK - Exited
First investment: 2008 - Start Up
Remote telemonitoring devices.
Orthovita: US - Exited
First investment: 2008 - Early Stage
Novel bone substitute materials.
Sirona Dental Systems: Germany - Exited
First investment: 2008 - Buy Out
Dental equipment manufacturer.
AcuFocus: US
First investment: 2008 - Seed
Based in Irvine, CA, AcuFocus is developing an implantable corneal in-lay for correction of presbyopia.
Argonaut Technologies: US - Exited
First investment: 2008 - Expansion
Chemistry instrumentation for accelerated synthesis of novel organic molecules. Bought by Biotage after our exit.
Cardiac Support Systems: US - Exited
First investment: 2008 - Seed
This was an innovation factory company.
CardioFocus: US
First investment: 2008 - Early Stage
Based in Marlborough, MA, CardioFocus has developed a catheter based approach using laser energy with visualization focused on atrial fibrillation.
Cerebral Vascular Applications: US
First investment: 2008 - Seed
Cerebral Vascular Applications incubated by TIF) developed a set of minimally invasive tools for atrial appendage sealing for stroke prevention. Licensed to Epitek.
Funded through the innovation factory
Confluent Surgical: US
First investment: 2008 - Early Stage
Biomaterials for adhesion prevention and vascular embolics.
Insulet: US
First investment HGLSF II: 2008 - Start Up
First investment HGLSF III: 2008 - Late Stage
Based in Bedford, MA, Insulet is designing and developing products that provide superior treatment for people with diabetes. The Company’s first commercial product is a wireless 3-day insulin pump.
Liposonix: US
First investment HGLSF II: 2008 - Seed
First investment HGLSF III: 2008 - Seed
Based in Bothell, WA, LipoSonix is developing a product to use non-invasive, high intensity focused ultrasound to ablate unwanted subcutaneous cells as a non-invasive alternative to liposuction for body sculpting.
Funded through the innovation factory.
Aquesys: US
First investment: 2008 - Early Stage
Based in Duluth, GA; AqueSys (TIF company) is developing an innovative approach to reducing intra-ocular pressure to treat glaucoma.
Cellutions: US
First investment: 2008 - Seed
Based in Duluth, GA, Cellutions (TIF)is developing a minimally invasive approach for addressing cellulite and its appearance on the skin.
CHF Solutions: US
First investment: 2008 - Expansion
Based in Brooklyn Park, MN, CHF has developed a mechanical pump/filter system to remove excess fluid from patients with acute de-compensated congestive heart failure. The product has US 510k clearance and is CE marked for both in-patient hospital care and out-patient clinic use.
Concentric Medical: US
First investment: 2008 - Expansion
Based in Mountain View, CA, Concentric is designing and developing products to open the pathway for stroke treatment. Their first device, the MERCI Retriever, removes clots associated with ischemic strokes.
EBR Systems: US
First investment: 2008 - Early Stage
EBR Systems is developing a wireless cardiac stimulation device (WiCS) to compete in the cardiac resynchronization therapy space for treatment of congestive heart failure.
Entellus: US
First investment: 2008 - Early Stage
Entellus is a company developing medical device therapies for nasal and sinus disease.
Eunoe: US - Exited
First investment: 2008 - Expansion
Treatment of neurological disorders through cerebrospinal fluid management (CSF).
Gyros: Sweden
First investment: 2008 - Start Up
Gyros, located in Uppsala, Sweden, has developed a proprietary microfluidics technology for processing and analysis of proteins and blood samples. Laboratory processes are integrated into a client specific disc (CD) format. The CD is processed and its contents analysed on software controlled instrumentation.
Insulet: US
First investment HGLSF II: 2008 - Start Up
First investment HGLSF III: 2008 - Late Stage
Based in Bedford, MA, Insulet is designing and developing products that provide superior treatment for people with diabetes. The Company’s first commercial product is a wireless 3-day insulin pump.
Liposonix: US
First investment HGLSF II: 2008 - Seed
First investment HGLSF III: 2008 - Seed
Based in Bothell, WA, LipoSonix is developing a product to use non-invasive, high intensity focused ultrasound to ablate unwanted subcutaneous cells as a non-invasive alternative to liposuction for body sculpting.
Funded through the innovation factory.
Neovista: US
First investment: 2008 - Seed
Based in Fremont, CA, NeoVista is developing a surgical device for controlled irradiation to target tissue for arresting the progression of neovascularization, the cause of Wet AMD.
OsteoLign: US
First investment: 2008 - Seed
Based in Duluth, GA; OsteoLign is developing a minimally invasive implant for long bone fixation.
ReShape: US
First investment: 2008 - Seed
ReShape is a seed stage project within the Intersect Partners incubator developing an endoscopically placed device for the treatment of obesity.
Sadra Medical: US
First investment: 2008 - Seed
Based in Campbell, CA, Sadra is developing an innovative new approach to aortic valve disease through a minimally invasive percutaneous replacement solution.
Spinal Kinetics: US
First investment: 2008 - Early Stage
Based in Redwood City, CA, Spinal Kinetics is developing a 3rd generation artificial disc for cervical and lumbar spine surgery as an alternative to fusion.
Cardiomind: US
First Investment: 2008 - Early Stage
CardioMind is a medical device company developing novel nitinol-based stents and an innovative, balloon-free stent delivery system for small, difficult-to-access vessels.
Halscion: US
First Investment: 2008 - Seed
Halscion is seed-stage company founded by The Innovation Factory which is developing a biomaterial for wound management.
i-Therapeutix: US
First Investment: 2008 - Start Up
i-Therapeutix is a medical device company that is currently engaged in development of in situ formed hydrogel therapeutic products specifically for ophthalmology.
MindFrame: US
First investment: 2008 - Seed
MindFrame is a seed stage company formed out of Intersect Partners developing a novel mechanical device for the treatment of ischemic stroke.
TransEnterix: US
First Investment: 2008 - Early Stage
Developing a surgical platform that provides all the benefits of a multi-port laparoscopic surgical approach while retaining a single port of entry through a natural body orifice or via the umbilicus.
